PRLD
#2915
Prelude Therapeutics Incorporated - Common Stock
6.3 4 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.35%
Variación mensual
+36.64%
Variación en los últimos 6 meses
+136.57%
Cambio anual
+391.47%
Cierres anteriores
6.5 6
Open
6.3 4
Mínimo
6.3 4
Máximo
6.3 4
Volumen
30
Financials
- Market Capitalization 505.95 M
- Employee 79
- Founded 2016
- CEO N/A
- Website www.preludetx.com
- Headquarter Delaware, United States
- FIGI BBG00K7JY2Q6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.25
Relación precio/flujo de caja
18.38
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2892 |  ENTX Entera Bio Ltd. - Ordinary Shares | 3.08 USD | -3.45% | -4.35% | -4.35% | +54.00% | 533.28 M USD | ||
| 2914 |  EDIT Editas Medicine, Inc. - Common Stock | 3.30 USD | +3.77% | +10.74% | +26.92% | +24.53% | 506.81 M USD | ||
| 2918 |  CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | +1.74% | +18.84% | +62.06% | 504.40 M USD | ||
| 2939 |  EVMN Evommune, Inc. Common Stock | 13.43 USD | -4.95% | -2.61% | +20.88% | -22.46% | 487.40 M USD |